RJA
SLAB icon

Raymond James & Associates’s Silicon Laboratories SLAB Stock Holding History

Raymond James & Associates’s Portfolio SLAB Stock Details SLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$7.58M Buy
65,623
+2,561
+4% +$286K ﹤0.01% 1384
2024
Q2 		$6.98M Sell
63,062
-28,106
-31% -$3.47M ﹤0.01% 1365
2024
Q1 		$13.1M Buy
91,168
+11,548
+15% +$1.53M 0.01% 1010
2023
Q4 		$10.5M Buy
79,620
+574
+0.7% +$62.8K 0.01% 1074
2023
Q3 		$9.16M Buy
79,046
+9,845
+14% +$1.36M 0.01% 1085
2023
Q2 		$10.9M Buy
69,201
+11,130
+19% +$1.68M 0.01% 1001
2023
Q1 		$10.2M Buy
58,071
+2,566
+5% +$431K 0.01% 1012
2022
Q4 		$7.53M Sell
55,505
-3,727
-6% -$490K 0.01% 1167
2022
Q3 		$7.31M Buy
59,232
+29,534
+99% +$3.95M 0.01% 1131
2022
Q2 		$4.16M Buy
29,698
+35
+0.1% +$4.9K ﹤0.01% 1522
2022
Q1 		$4.46M Buy
29,663
+168
+0.6% +$26.8K ﹤0.01% 1591
2021
Q4 		$6.09M Sell
29,495
-2,533
-8% -$466K ﹤0.01% 1424
2021
Q3 		$4.49M Buy
32,028
+1,660
+5% +$249K ﹤0.01% 1564
2021
Q2 		$4.65M Sell
30,368
-293
-1% -$41K ﹤0.01% 1536
2021
Q1 		$4.33M Sell
30,661
-780
-2% -$112K ﹤0.01% 1511
2020
Q4 		$4M Buy
31,441
+5,785
+23% +$652K ﹤0.01% 1460
2020
Q3 		$2.51M Buy
25,656
+439
+2% +$44.1K ﹤0.01% 1612
2020
Q2 		$2.53M Buy
25,217
+3,823
+18% +$357K ﹤0.01% 1584
2020
Q1 		$1.83M Sell
21,394
-740
-3% -$73.4K ﹤0.01% 1622
2019
Q4 		$2.57M Sell
22,134
-316
-1% -$34.7K ﹤0.01% 1671
2019
Q3 		$2.5M Buy
22,450
+5
+0% +$541 ﹤0.01% 1635
2019
Q2 		$2.32M Sell
22,445
-15,818
-41% -$1.53M ﹤0.01% 1711
2019
Q1 		$3.09M Buy
38,263
+16,173
+73% +$1.35M ﹤0.01% 1492
2018
Q4 		$1.74M Sell
22,090
-1,260
-5% -$105K ﹤0.01% 1745
2018
Q3 		$2.14M Sell
23,350
-2,206
-9% -$216K ﹤0.01% 1769
2018
Q2 		$2.54M Buy
25,556
+1,509
+6% +$151K ﹤0.01% 1610
2018
Q1 		$2.16M Buy
24,047
+7,803
+48% +$736K ﹤0.01% 1651
2017
Q4 		$1.43M Buy
16,244
+872
+6% +$78.4K ﹤0.01% 1912
2017
Q3 		$1.23M Buy
+15,372
New +$1.14M ﹤0.01% 1971

Other funds holding SLAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Raymond James & Associates's SLAB Position: Q3 2024 in Review

Raymond James & Associates increased its Silicon Laboratories (SLAB) stake by 4.1% in Q3 2024, buying an estimated $286K and bringing the position to 65,623 shares worth $7.58M. The position accounts for ﹤0.01% of the portfolio, ranked #1384.

Raymond James & Associates first reported a position in SLAB in Q3 2017 and has held it in 29 quarters since. The position peaked at $13.1M in Q1 2024. 302 funds tracked by Wall St. Rank hold SLAB as of Q3 2024.

  • Raymond James & Associates held 65,623 shares of Silicon Laboratories worth $7.58M as of Q3 2024.
  • Raymond James & Associates bought 2,561 Silicon Laboratories shares in Q3 2024, an estimated $286K.
  • Silicon Laboratories made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1384 holding.
  • Raymond James & Associates first reported a position in Silicon Laboratories in Q3 2017 and has held it in 29 quarters since.
  • Raymond James & Associates's Silicon Laboratories position peaked at $13.1M in Q1 2024.
  • 302 funds tracked by Wall St. Rank held Silicon Laboratories as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.